Anti Neurofilament L Antibody Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: ACB5141562F2EN
Market Monitor Global

Abstracts

Neurofilament is a type of filament that is required for the cytoskeleton of a neuron that supports the axon cytoplasm. The neurofilaments are the most common types of fibrillar component s that are available in the axon.

This report contains market size and forecasts of Anti Neurofilament L Antibody in Global, including the following market information:

Global Anti Neurofilament L Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti Neurofilament L Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Mouse Anti Neurofilament L Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti Neurofilament L Antibody include Merck, BioLegend, Cell Signaling Technology, Rockland Immunochemicals, Bio-Rad Laboratories and EnCor Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti Neurofilament L Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti Neurofilament L Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti Neurofilament L Antibody Market Segment Percentages, by Type, 2021 (%)

• Mouse Anti Neurofilament L Antibody
• Rabbit Anti Neurofilament L Antibody
• Others

Global Anti Neurofilament L Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti Neurofilament L Antibody Market Segment Percentages, by Application, 2021 (%)

• Academic and Research Institutes
• Pharma and Biotech Companies
• Others

Global Anti Neurofilament L Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti Neurofilament L Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti Neurofilament L Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti Neurofilament L Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• BioLegend
• Cell Signaling Technology
• Rockland Immunochemicals
• Bio-Rad Laboratories
• EnCor Biotechnology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti Neurofilament L Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti Neurofilament L Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI NEUROFILAMENT L ANTIBODY OVERALL MARKET SIZE

2.1 Global Anti Neurofilament L Antibody Market Size: 2021 VS 2028
2.2 Global Anti Neurofilament L Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti Neurofilament L Antibody Players in Global Market
3.2 Top Global Anti Neurofilament L Antibody Companies Ranked by Revenue
3.3 Global Anti Neurofilament L Antibody Revenue by Companies
3.4 Top 3 and Top 5 Anti Neurofilament L Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti Neurofilament L Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti Neurofilament L Antibody Players in Global Market
  3.6.1 List of Global Tier 1 Anti Neurofilament L Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti Neurofilament L Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti Neurofilament L Antibody Market Size Markets, 2021 & 2028
  4.1.2 Mouse Anti Neurofilament L Antibody
  4.1.3 Rabbit Anti Neurofilament L Antibody
  4.1.4 Others
4.2 By Type - Global Anti Neurofilament L Antibody Revenue & Forecasts
  4.2.1 By Type - Global Anti Neurofilament L Antibody Revenue, 2017-2022
  4.2.2 By Type - Global Anti Neurofilament L Antibody Revenue, 2023-2028
  4.2.3 By Type - Global Anti Neurofilament L Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti Neurofilament L Antibody Market Size, 2021 & 2028
  5.1.2 Academic and Research Institutes
  5.1.3 Pharma and Biotech Companies
  5.1.4 Others
5.2 By Application - Global Anti Neurofilament L Antibody Revenue & Forecasts
  5.2.1 By Application - Global Anti Neurofilament L Antibody Revenue, 2017-2022
  5.2.2 By Application - Global Anti Neurofilament L Antibody Revenue, 2023-2028
  5.2.3 By Application - Global Anti Neurofilament L Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti Neurofilament L Antibody Market Size, 2021 & 2028
6.2 By Region - Global Anti Neurofilament L Antibody Revenue & Forecasts
  6.2.1 By Region - Global Anti Neurofilament L Antibody Revenue, 2017-2022
  6.2.2 By Region - Global Anti Neurofilament L Antibody Revenue, 2023-2028
  6.2.3 By Region - Global Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti Neurofilament L Antibody Revenue, 2017-2028
  6.3.2 US Anti Neurofilament L Antibody Market Size, 2017-2028
  6.3.3 Canada Anti Neurofilament L Antibody Market Size, 2017-2028
  6.3.4 Mexico Anti Neurofilament L Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti Neurofilament L Antibody Revenue, 2017-2028
  6.4.2 Germany Anti Neurofilament L Antibody Market Size, 2017-2028
  6.4.3 France Anti Neurofilament L Antibody Market Size, 2017-2028
  6.4.4 U.K. Anti Neurofilament L Antibody Market Size, 2017-2028
  6.4.5 Italy Anti Neurofilament L Antibody Market Size, 2017-2028
  6.4.6 Russia Anti Neurofilament L Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries Anti Neurofilament L Antibody Market Size, 2017-2028
  6.4.8 Benelux Anti Neurofilament L Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti Neurofilament L Antibody Revenue, 2017-2028
  6.5.2 China Anti Neurofilament L Antibody Market Size, 2017-2028
  6.5.3 Japan Anti Neurofilament L Antibody Market Size, 2017-2028
  6.5.4 South Korea Anti Neurofilament L Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia Anti Neurofilament L Antibody Market Size, 2017-2028
  6.5.6 India Anti Neurofilament L Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti Neurofilament L Antibody Revenue, 2017-2028
  6.6.2 Brazil Anti Neurofilament L Antibody Market Size, 2017-2028
  6.6.3 Argentina Anti Neurofilament L Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti Neurofilament L Antibody Revenue, 2017-2028
  6.7.2 Turkey Anti Neurofilament L Antibody Market Size, 2017-2028
  6.7.3 Israel Anti Neurofilament L Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti Neurofilament L Antibody Market Size, 2017-2028
  6.7.5 UAE Anti Neurofilament L Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Anti Neurofilament L Antibody Major Product Offerings
  7.1.4 Merck Anti Neurofilament L Antibody Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 BioLegend
  7.2.1 BioLegend Corporate Summary
  7.2.2 BioLegend Business Overview
  7.2.3 BioLegend Anti Neurofilament L Antibody Major Product Offerings
  7.2.4 BioLegend Anti Neurofilament L Antibody Revenue in Global Market (2017-2022)
  7.2.5 BioLegend Key News
7.3 Cell Signaling Technology
  7.3.1 Cell Signaling Technology Corporate Summary
  7.3.2 Cell Signaling Technology Business Overview
  7.3.3 Cell Signaling Technology Anti Neurofilament L Antibody Major Product Offerings
  7.3.4 Cell Signaling Technology Anti Neurofilament L Antibody Revenue in Global Market (2017-2022)
  7.3.5 Cell Signaling Technology Key News
7.4 Rockland Immunochemicals
  7.4.1 Rockland Immunochemicals Corporate Summary
  7.4.2 Rockland Immunochemicals Business Overview
  7.4.3 Rockland Immunochemicals Anti Neurofilament L Antibody Major Product Offerings
  7.4.4 Rockland Immunochemicals Anti Neurofilament L Antibody Revenue in Global Market (2017-2022)
  7.4.5 Rockland Immunochemicals Key News
7.5 Bio-Rad Laboratories
  7.5.1 Bio-Rad Laboratories Corporate Summary
  7.5.2 Bio-Rad Laboratories Business Overview
  7.5.3 Bio-Rad Laboratories Anti Neurofilament L Antibody Major Product Offerings
  7.5.4 Bio-Rad Laboratories Anti Neurofilament L Antibody Revenue in Global Market (2017-2022)
  7.5.5 Bio-Rad Laboratories Key News
7.6 EnCor Biotechnology
  7.6.1 EnCor Biotechnology Corporate Summary
  7.6.2 EnCor Biotechnology Business Overview
  7.6.3 EnCor Biotechnology Anti Neurofilament L Antibody Major Product Offerings
  7.6.4 EnCor Biotechnology Anti Neurofilament L Antibody Revenue in Global Market (2017-2022)
  7.6.5 EnCor Biotechnology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti Neurofilament L Antibody Market Opportunities & Trends in Global Market
Table 2. Anti Neurofilament L Antibody Market Drivers in Global Market
Table 3. Anti Neurofilament L Antibody Market Restraints in Global Market
Table 4. Key Players of Anti Neurofilament L Antibody in Global Market
Table 5. Top Anti Neurofilament L Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti Neurofilament L Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti Neurofilament L Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti Neurofilament L Antibody Product Type
Table 9. List of Global Tier 1 Anti Neurofilament L Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti Neurofilament L Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti Neurofilament L Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti Neurofilament L Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti Neurofilament L Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti Neurofilament L Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti Neurofilament L Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti Neurofilament L Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti Neurofilament L Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti Neurofilament L Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti Neurofilament L Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti Neurofilament L Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti Neurofilament L Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti Neurofilament L Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti Neurofilament L Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti Neurofilament L Antibody Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Anti Neurofilament L Antibody Product Offerings
Table 32. Merck Anti Neurofilament L Antibody Revenue (US$, Mn), (2017-2022)
Table 33. BioLegend Corporate Summary
Table 34. BioLegend Anti Neurofilament L Antibody Product Offerings
Table 35. BioLegend Anti Neurofilament L Antibody Revenue (US$, Mn), (2017-2022)
Table 36. Cell Signaling Technology Corporate Summary
Table 37. Cell Signaling Technology Anti Neurofilament L Antibody Product Offerings
Table 38. Cell Signaling Technology Anti Neurofilament L Antibody Revenue (US$, Mn), (2017-2022)
Table 39. Rockland Immunochemicals Corporate Summary
Table 40. Rockland Immunochemicals Anti Neurofilament L Antibody Product Offerings
Table 41. Rockland Immunochemicals Anti Neurofilament L Antibody Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Rad Laboratories Corporate Summary
Table 43. Bio-Rad Laboratories Anti Neurofilament L Antibody Product Offerings
Table 44. Bio-Rad Laboratories Anti Neurofilament L Antibody Revenue (US$, Mn), (2017-2022)
Table 45. EnCor Biotechnology Corporate Summary
Table 46. EnCor Biotechnology Anti Neurofilament L Antibody Product Offerings
Table 47. EnCor Biotechnology Anti Neurofilament L Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti Neurofilament L Antibody Segment by Type in 2021
Figure 2. Anti Neurofilament L Antibody Segment by Application in 2021
Figure 3. Global Anti Neurofilament L Antibody Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti Neurofilament L Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti Neurofilament L Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti Neurofilament L Antibody Revenue in 2021
Figure 8. By Type - Global Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
Figure 12. US Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
Figure 16. Germany Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
Figure 24. China Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti Neurofilament L Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti Neurofilament L Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Anti Neurofilament L Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioLegend Anti Neurofilament L Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cell Signaling Technology Anti Neurofilament L Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Rockland Immunochemicals Anti Neurofilament L Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Rad Laboratories Anti Neurofilament L Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. EnCor Biotechnology Anti Neurofilament L Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)